BACTIQ — Bactiquant A/S Share Price
Last trade - 00:00- DKK61.09m
- DKK49.92m
- DKK12.30m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.24 | ||
| Price to Tang. Book | 7.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.97 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -51.76% | ||
| Return on Equity | -91.26% | ||
| Operating Margin | -96.13% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKKm | 15.5 | 5.48 | 8.36 | 12.39 | 12.3 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +52.96 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Bactiquant A/S is a Denmark-based Company developing a technology, which aims to monitor bacterial contamination levels in water. Bactiquant operates through seven business segments: Aquaculture, Water Utility, Industry, Data Centres, Oil and Gas, Legionella Risk Assessment and Research Institutions. The Company serves customers that come from such industries as public water utility companies, industries needing water cooling or requiring wastewater treatment, as well as aquaculture and operates in five continents.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- July 1st, 1999
- Public Since
- February 5th, 2021
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange - Copenhagen
- Shares in Issue
- 23,497,485
- Address
- Blokken 75, BIRKEROED, 3460
- Web
- https://bactiquant.com/
- Phone
- Auditors
- KPMG Statsautoriseret Revisionspartnerselskab
Upcoming Events for BACTIQ
Similar to BACTIQ
Ambu A/S
OMX Nordic Exchange - Copenhagen
BioPorto A/S
OMX Nordic Exchange - Copenhagen
ChemoMetec A/S
OMX Nordic Exchange - Copenhagen
Coloplast A/S
OMX Nordic Exchange - Copenhagen
Demant A/S
OMX Nordic Exchange - Copenhagen
FAQ
As of Today at 19:03 UTC, shares in Bactiquant A/S are trading at DKK2.60. This share price information is delayed by 15 minutes.
Shares in Bactiquant A/S last closed at DKK2.60 and the price had moved by -59.46% over the past 365 days. In terms of relative price strength the Bactiquant A/S share price has underperformed the FTSE Global All Cap Index by -61.94% over the past year.
There is no consensus recommendation for this security.
Bactiquant A/S does not currently pay a dividend.
Bactiquant A/S does not currently pay a dividend.
Bactiquant A/S does not currently pay a dividend.
To buy shares in Bactiquant A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of DKK2.60, shares in Bactiquant A/S had a market capitalisation of DKK61.09m.
Here are the trading details for Bactiquant A/S:
- Country of listing: Denmark
- Exchange: CPH
- Ticker Symbol: BACTIQ
Based on an overall assessment of its quality, value and momentum Bactiquant A/S is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Bactiquant A/S. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -37.87%.
As of the last closing price of DKK2.60, shares in Bactiquant A/S were trading -30.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Bactiquant A/S PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at DKK2.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Bactiquant A/S' directors